CSL Behring
Study Shows C1-Esterase Inhibitor Concentrate Rapidly Relieves Acute, Successive Attacks of Hereditary Angioedema at All Body Sites
Published in Genetics and Environmental Business Week, March 18th, 2010
C1-esterase inhibitor (C1-INH) concentrate is an effective, well-tolerated therapy that rapidly relieves acute swelling attacks and successive attacks at any body location in patients with hereditary angioedema (HAE), a rare and serious genetic disorder, according to data presented today at the 2010 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting. Additional pharmacokinetic data presented at the meeting confirms that C1-INH concentrate has a longer half-life than other treatment options for HAE, which protects patients from rebound attacks.
The latest results from the ongoing, prospective, open label International Multi-center Prospective...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Genetics and Environmental Business Week
More Articles from Genetics and Environmental Business Week
- Antisense Technology
Isis Reports Strong Financial Results and Highlights for 2009 - Argos Therapeutics
Argos Therapeutics Publishes Positive Immune Response, Safety and Manufacturing Data for its Arcelis(TM) HIV Program in Clinical Immunology - BioSante Pharmaceuticals, Inc.
BioSante Pharmaceuticals Receives Two New Patents for Manufacture of Proteins, Including Antibodies - Breast Cancer
Synthetic lethality: a new way to kill cancer cells - Cytovance Biologics LLC
Cytovance(R) Biologics Announces Business Development Focus in International Markets and Promotion of New Vice President of Sales & Business Development - North America - Diabetes
Researchers Uncover Gene's Role in Preventing Beta-Cell Death - More from this issue of Genetics and Environmental Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
